Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Referring vulval skin disease to a vulval clinic
Shireen S Velangi
The prevalence and importance of vulval skin disease is likely to be underestimated. Women may delay seeing a doctor because of embarrassment or worries about a possible infectious cause of their condition and many have tried over the counter ‘antipruritic’ or ‘anti-thrush’ preparations. It is estimated that GPs see three or more patients per month with vulval complaints. However, this is set to rise with increasing information in the media and via the internet. This article will outline the general approach and management of women seen in a vulval clinic, including some of the more common conditions encountered, and may help to identify the types of patient that could benefit from referral to a vulval clinic.
Dermatology in practice
2002;
10
(5): 22–26
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
EMA committee recommends Galderma’s nemolizumab for prurigo nodularis and atopic dermatitis
LEO Pharma receives MHRA approval for Anzupgo cream in chronic hand eczema
Galderma shares positive phase 3 data for nemolizumab in prurigo nodularis
J&J/Protagonist’s icotrokinra shows promise in phase 3 plaque psoriasis trial
UCB’s Bimzelx approved by FDA to treat hidradenitis suppurativa
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy